Integrative characterization of chronic cigarette smoke-induced cardiopulmonary comorbidities in a mouse model

• DOI: 10.1016/j.envpol.2017.04.098
• Publication Date: 2017-06-22T18:30:37Z
• Authors: Ágnes Kemény; Kata Csekő; István Szitter; Zoltán V. Varga; Péter Bencsik; Krisztina Kiss; Róbert Halmosi; László Deres; Krisztián Erős; Anikó Perkecz; László Kereskai; Terézia László; Tamás Kiss; Péter Ferdinandy; Zsuzsanna Helyes
• Keywords: Inflammation; Nicotiana; 0303 health sciences; Smoking; 610; Comorbidity; 3. Good health; Mice, Inbred C57BL; Disease Models, Animal; Interleukin 1 Receptor Antagonist Protein; Mice; Pulmonary Disease, Chronic Obstructive; 03 medical and health sciences; Pulmonary Emphysema; Interleukin-1alpha; Smoke; R850-854 Experimental medicine / kisérleti orvostudomány; Animals; Tobacco Smoke Pollution; Bronchoalveolar Lavage Fluid; Lung

Cigarette smoke-triggered inflammatory cascades and consequent tissue damage are the main causes of chronic obstructive pulmonary disease (COPD). There is no effective therapy and the key mediators of COPD are not identified due to the lack of translational animal models with complex characterization. This integrative chronic study investigated cardiopulmonary pathophysiological alterations and mechanisms with functional, morphological and biochemical techniques in a 6-month-long cigarette smoke exposure mouse model. Some respiratory alterations characteristic of emphysema (decreased airway resistance: Rl; end-expiratory work and pause: EEW, EEP; expiration time: Te; increased tidal mid-expiratory flow: EF50) were detected in anaesthetized C57BL/6 mice, unrestrained plethysmography did not show changes. Typical histopathological signs were peribronchial/perivascular (PB/PV) edema at month 1, neutrophil/macrophage infiltration at month 2, interstitial leukocyte accumulation at months 3-4, and emphysema/atelectasis at months 5-6 quantified by mean linear intercept measurement. Emphysema was proven by micro-CT quantification. Leukocyte number in the bronchoalveolar lavage at month 2 and lung matrix metalloproteinases-2 and 9 (MMP-2/MMP-9) activities in months 5-6 significantly increased. Smoking triggered complex cytokine profile change in the lung with one characteristic inflammatory peak of C5a, interleukin-1α and its receptor antagonist (IL-1α, IL-1ra), monokine induced by gamma interferon (MIG), macrophage colony-stimulating factor (M-CSF), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) at months 2-3, and another peak of interferon-γ (IFN-γ), IL-4, 7, 13, 17, 27 related to tissue destruction. Transient systolic and diastolic ventricular dysfunction developed after 1-2 months shown by significantly decreased ejection fraction (EF%) and deceleration time, respectively. These parameters together with the tricuspid annular plane systolic excursion (TAPSE) decreased again after 5-6 months. Soluble intercellular adhesion molecule-1 (sICAM-1) significantly increased in the heart homogenates at month 6, while other inflammatory cytokines were undetectable. This is the first study demonstrating smoking duration-dependent, complex cardiopulmonary alterations characteristic to COPD, in which inflammatory cytokine cascades and MMP-2/9 might be responsible for pulmonary destruction and sICAM-1 for heart dysfunction.